MD HB887 | 2017 | Regular Session

Status

Completed Legislative Action
Spectrum: Slight Partisan Bill (Democrat 16-10)
Status: Passed on May 25 2017 - 100% progression
Action: 2017-05-25 - Approved by the Governor - Chapter 581
Text: Latest bill text (Chaptered) [PDF]

Summary

Prohibiting specified insurers, nonprofit health service plans, and health maintenance organizations from applying a preauthorization requirement for a prescription drug to be used for treatment of an opioid use disorder and that contains methadone, buprenorphine, or naltrexone; and applying the Act to all policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or after the effective date of the Act.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Health Insurance - Prior Authorization for Drug Products to Treat an Opioid Use Disorder - Prohibition

Sponsors


Roll Calls

2017-04-02 - Senate - Senate Floor - Third Reading Passed (45-0) (Y: 45 N: 0 NV: 1 Abs: 1) [PASS]
2017-03-13 - House - House Floor - Third Reading Passed (141-0) (Y: 141 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2017-05-25HouseApproved by the Governor - Chapter 581
2017-04-10HouseReturned Passed
2017-04-10SenateThird Reading Passed (45-0)
2017-04-06SenateSecond Reading Passed
2017-04-06SenateFavorable Report Adopted
2017-04-06SenateFavorable Report by Finance
2017-04-04SenateHearing 4/04 at 1:00 p.m.
2017-03-17SenateFirst Reading Finance
2017-03-16HouseThird Reading Passed (141-0)
2017-03-15HouseSecond Reading Passed with Amendments
2017-03-15HouseFloor Committee Amendment {286185/1 Adopted
2017-03-15HouseFavorable with Amendments {796789/1 Report Adopted
2017-03-14HouseFavorable with Amendments Report by Health and Government Operations
2017-03-02HouseHearing 3/02 at 1:00 p.m.
2017-02-06HouseFirst Reading Health and Government Operations

Subjects


Maryland State Sources

TypeSource
Summaryhttps://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0887?ys=2017rs
Texthttps://mgaleg.maryland.gov/2017RS/bills/hb/hb0887f.pdf
Texthttps://mgaleg.maryland.gov/2017RS/bills/hb/hb0887t.pdf
Texthttps://mgaleg.maryland.gov/2017RS/Chapters_noln/CH_581_hb0887t.pdf
Amendmenthttps://mgaleg.maryland.gov/2017RS/amds/bil_0007/hb0887_28618501.pdf
Amendmenthttps://mgaleg.maryland.gov/2017RS/amds/bil_0007/hb0887_79678901.pdf
Supplementhttps://mgaleg.maryland.gov/2017RS/fnotes/bil_0007/hb0887.pdf
Supplementhttps://mgaleg.maryland.gov/2017RS/votes_comm/hb0887_hgo.pdf
Supplementhttps://mgaleg.maryland.gov/2017RS/votes_comm/hb0887_fin.pdf
Roll Callhttps://mgaleg.maryland.gov/webmga/frmMain.aspx?pid=flrvotepage&tab=subject3&id=hb0887,h-0562&stab=02&ys=2017RS
Roll Callhttps://mgaleg.maryland.gov/webmga/frmMain.aspx?pid=flrvotepage&tab=subject3&id=hb0887,s-1284&stab=02&ys=2017RS

Bill Comments

feedback